OAS2 antibody (AA 401-500)
Quick Overview for OAS2 antibody (AA 401-500) (ABIN1713688)
Target
See all OAS2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 401-500
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Dog,Pig
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human OAS2
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- OAS2 (2'-5'-Oligoadenylate Synthetase 2, 69/71kDa (OAS2))
-
Alternative Name
- OAS2
-
Background
-
Synonyms: 2-5''oligoA synthase 2, 2-5'oligoA synthetase 2, 2''-5''-oligoadenylate synthase 2, 2'-5'-oligoadenylate synthetase 2, 2'-5'-oligoadenylate synthetase 2, 69/71 kDa, 2-5A synthase 2, 2-5A synthetase 2, MGC78578, OAS2, OAS2_HUMAN, p69 OAS / p71 OAS, p69OAS / p71OAS.
Background: This gene encodes a member of the 2-5A synthetase family, essential proteins involved in the innate immune response to viral infection. The encoded protein is induced by interferons and uses adenosine triphosphate in 2'-specific nucleotidyl transfer reactions to synthesize 2',5'-oligoadenylates (2-5As). These molecules activate latent RNase L, which results in viral RNA degradation and the inhibition of viral replication. The three known members of this gene family are located in a cluster on chromosome 12. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].
-
Pathways
- Hepatitis C
Target
-